Galapagos NV
GLPG
#4536
Rank
ยฃ1.61 B
Marketcap
ยฃ24.16
Share price
2.21%
Change (1 day)
13.18%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -ยฃ0.4 Billion

According to Galapagos NV's latest financial reports the company's current earnings are ยฃ0.32 Billion. In 2024 the company made an earning of -ยฃ4.32 Million, an increase over its 2023 earnings that were of -ยฃ25.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.4 Billion9121.36%
2024 -ยฃ4.32 Million-82.77%
2023 -ยฃ25.07 Million-85.59%
2022 -ยฃ0.18 Billion60.71%
2021 -ยฃ0.11 Billion-60.08%
2020 -ยฃ0.28 Billion-331.44%
2019 ยฃ0.11 B-523.76%
2018 -ยฃ27.65 Million-72.34%
2017 -ยฃ99.97 Million-329.59%
2016 ยฃ43.54 M-144.3%
2015 -ยฃ98.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
ยฃ9.78 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
ยฃ24.20 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.79 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
ยฃ1.24 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-ยฃ66.47 Million-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.08 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.32 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ6.96 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ17.25 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA